Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RYTM
#1020
Rhythm Pharmaceuticals, Inc. Common Stock
92.730
0
-4.28%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-4.28%
Variazione Mensile
-11.82%
Variazione di 6 mesi
-15.94%
Variazione Annuale
-15.94%
Chiusura Precedente
96.880
0
Open
92.830
0
Bid
Ask
Low
92.730
0
High
92.830
0
Volume
161
Mercati
Mercato Azionario Statunitense
Salute
RYTM
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
61.46 M
63.22 M
63.62 M
66.42 M
66.74 M
68.29 M
—
Valuation ratios
Enterprise value
3.17 B
3.45 B
3.26 B
4.06 B
6.69 B
7.25 B
21.27 B
Price to earnings ratio
141.37
-12.9
-18.92
-21.06
-32.68
-34.42
-107.08
Price to sales ratio
27.99
26.24
23.82
25.18
36.86
—
—
Price to cash flow ratio
25.24
29.98
28.83
36.59
58.83
60.13
184.39
Price to book ratio
10.93
157.14
35.68
61.54
32.69
50.02
179.92
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.12
0.11
0.13
0.13
0.1
0.1
0.46
Return on equity %
3.89
1.99
2.61
3.92
0.36
0.34
7.23
Return on invested capital %
397.03
280.37
321.98
206.59
200.79
328.63
1 057.99
Gross margin %
88.49
90.95
88.85
88.57
89.28
91.61
358.31
Operating margin %
131.98
98.62
143.73
93.39
102.64
82.2
421.96
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
131.36
103.5
151.35
96.14
103.13
82.97
433.6
Liquidity ratios
Quick ratio
3.34
3.08
3.13
2.64
4.53
4.16
14.47
Current ratio
3.49
3.24
3.3
2.79
4.75
4.41
15.24
Inventory turnover
0.3
0.23
0.19
0.29
0.27
0.2
0.95
Asset turnover
0.09
0.11
0.08
0.13
0.12
0.12
0.44
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.28
0.28
0.28
0.2
0.21
0.98
Long term debt to total equity ratio
—
4.98
5.7
8.9
0.69
0.73
16.02
Per share metrics
Operating cash flow per share
0.41
0.31
0.64
0.37
0.4
0.39
1.8
EBIT per share
-0.72
-0.68
-0.75
-0.71
-0.79
-0.72
-2.98
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.87
5.26
4.99
4.57
6.28
5.98
21.82
Net current asset value per share
5.56
6.13
5.86
5.66
7.47
7.19
26.17
Tangible book value per share
0.08
0.26
0.21
0.1
2.16
2.06
4.52
Working capital per share
3.96
4.24
4.08
3.63
5.89
5.55
19.16
Book value per share
0.18
0.36
0.3
0.19
2.25
2.14
4.87
Notizie
Guggenheim上调Rhythm Pharmaceuticals目标价,基于公司业绩指引
Guggenheim raises Rhythm Pharmaceuticals stock price target on guidance
Citizens上调Rhythm Pharmaceuticals目标价,看好HO适应症获批前景
Citizens raises Rhythm Pharmaceuticals stock price target on HO approval outlook
Stifel重申Rhythm Pharmaceuticals股票买入评级,目标价131美元
Stifel reiterates Buy on Rhythm Pharmaceuticals stock, $131 target
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
Rhythm Pharma 2025年第四季度业绩:营收超预期,HO适应症获批在即
Rhythm Pharma Q4 2025 slides: revenue beats as HO launch nears
Rhythm PharmaQ4每股收益及营收超出预期
Rhythm Pharma earnings beat by $0.09, revenue topped estimates
Rhythm Pharma财报公布在即,关键肥胖症批准决定临近